Organon & Co. 8-K

What Happened
Organon & Co. announced that its stockholders approved an amendment and restatement of the Organon & Co. 2021 Incentive Stock Plan (the “Amended and Restated 2021 ISP”) at the Company’s Annual Meeting held on June 9, 2026. The Board, following a Talent Committee recommendation, had previously approved the amendment on April 14, 2026, subject to shareholder approval. The full text of the Amended and Restated 2021 ISP is included as Appendix B to Organon’s definitive proxy statement filed April 24, 2026 and is incorporated by reference in the company’s 8‑K as Exhibit 10.1.

Key Details

• Annual Meeting date: June 9, 2026; 8‑K filing date: June 11, 2026.
• Board/Talent Committee approval date (subject to shareholder vote): April 14, 2026.
• The Amended and Restated 2021 ISP text is in Organon’s Proxy Statement filed April 24, 2026 and is incorporated as Exhibit 10.1.
• The 8‑K reports the plan amendment under Item 5.02 (director/officer/compensation matters) and refers to voting results under Item 5.07.

Why It Matters
Approval of the Amended and Restated 2021 Incentive Stock Plan lets Organon grant equity‑based awards under the updated plan terms. For investors, changes to an incentive plan can affect future executive and employee compensation, potential share dilution, and how the company uses stock‑based incentives to retain and motivate staff. Review the incorporated plan text in the Proxy Statement for specifics on grant limits, eligibility, and any changes that could influence outstanding shares or compensation expense.